Switch theme
Sign up to access all valuation multiples
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
1998
9.8K+
LTM Revenue $833M
LTM EBITDA $194M
$3.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Asymchem Laboratories has a last 12-month revenue of $833M and a last 12-month EBITDA of $194M.
In the most recent fiscal year, Asymchem Laboratories achieved revenue of $1.1B and an EBITDA of $416M.
Asymchem Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Asymchem Laboratories valuation multiples based on analyst estimates| FY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.1B | $812M | $833M | XXX |
| Gross Profit | $282M | $667M | $550M | XXX | XXX |
| Gross Margin | 20% | 62% | 68% | XXX | XXX |
| EBITDA | $560M | $416M | $188M | $194M | XXX |
| EBITDA Margin | 40% | 39% | 23% | 23% | XXX |
| Net Profit | $147M | $453M | $311M | XXX | XXX |
| Net Margin | 10% | 42% | 38% | XXX | XXX |
| Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Asymchem Laboratories's stock price is CNY 86 (or $12).
Asymchem Laboratories has current market cap of CNY 31.5B (or $4.3B), and EV of CNY 24.4B (or $3.4B).
See Asymchem Laboratories trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.4B | $4.3B | XXX | XXX | XXX | XXX | $0.40 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Asymchem Laboratories has market cap of $4.3B and EV of $3.4B.
Asymchem Laboratories's trades at 4.0x LTM EV/Revenue multiple, and 17.2x LTM EBITDA.
Analysts estimate Asymchem Laboratories's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Asymchem Laboratories and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.4B | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | 17.9x | XXX | XXX | XXX |
| P/E | 30.9x | XXX | XXX | XXX |
| P/E/Growth | 1.3x | XXX | XXX | XXX |
| EV/FCF | 20.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAsymchem Laboratories's NTM/LTM revenue growth is 17%
Asymchem Laboratories's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $24K for the same period.
Over next 12 months, Asymchem Laboratories's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Asymchem Laboratories's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Asymchem Laboratories and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -24% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -55% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 40% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $24K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 22% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
| Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
| Suven Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Asymchem Laboratories acquired XXX companies to date.
Last acquisition by Asymchem Laboratories was XXXXXXXX, XXXXX XXXXX XXXXXX . Asymchem Laboratories acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Asymchem Laboratories founded? | Asymchem Laboratories was founded in 1998. |
| Where is Asymchem Laboratories headquartered? | Asymchem Laboratories is headquartered in China. |
| How many employees does Asymchem Laboratories have? | As of today, Asymchem Laboratories has 9.8K+ employees. |
| Who is the CEO of Asymchem Laboratories? | Asymchem Laboratories's CEO is Dr. Hao Hong. |
| Is Asymchem Laboratories publicy listed? | Yes, Asymchem Laboratories is a public company listed on SHE. |
| What is the stock symbol of Asymchem Laboratories? | Asymchem Laboratories trades under 002821 ticker. |
| When did Asymchem Laboratories go public? | Asymchem Laboratories went public in 2016. |
| Who are competitors of Asymchem Laboratories? | Similar companies to Asymchem Laboratories include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
| What is the current market cap of Asymchem Laboratories? | Asymchem Laboratories's current market cap is $4.3B |
| What is the current revenue of Asymchem Laboratories? | Asymchem Laboratories's last 12-month revenue is $833M. |
| What is the current EBITDA of Asymchem Laboratories? | Asymchem Laboratories's last 12-month EBITDA is $194M. |
| What is the current EV/Revenue multiple of Asymchem Laboratories? | Current revenue multiple of Asymchem Laboratories is 4.0x. |
| What is the current EV/EBITDA multiple of Asymchem Laboratories? | Current EBITDA multiple of Asymchem Laboratories is 17.2x. |
| What is the current revenue growth of Asymchem Laboratories? | Asymchem Laboratories revenue growth between 2023 and 2024 was -24%. |
| Is Asymchem Laboratories profitable? | Yes, Asymchem Laboratories is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
